Module 1 2021

28/06/2021

Life Cycle Management Regulatory issues and strategies

Sjaak Bot, Senior Advisor Global Regulatory Affairs, Janssen July 2 nd , 2021

Begin with the end in mind But what is the end….?

The Organisation for Professionals in Regulatory Affairs

1

The opinions expressed are my own and not necessarily the opinions of the Janssen Pharmaceutical Companies of Johnson & Johnson, or any other organization or individual.

I am an employee and shareholder of Johnson & Johnson

Sjaak Bot Senior Advisor Global Regulatory Affairs Janssen

The Organisation for Professionals in Regulatory Affairs

2

2

1